We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TSN:NYSETyson Foods, Inc. Analysis

Data as of 2026-03-11 - not real-time

$60.24

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Tyson Foods (TSN) is trading at $60.24, which sits below its 20‑day SMA of $63.23 but above the 200‑day SMA of $56.77, indicating a mixed short‑term technical picture within a longer‑term bullish trend. The RSI of 36.6 suggests the stock is approaching oversold territory, while a bearish MACD histogram reinforces near‑term downside pressure. Support around $59.78 is holding, but resistance near $65.95 looms, limiting upside unless a breakout occurs. Fundamentally, the company’s PE ratio of 107.6 and forward PE of 13.6 highlight severe overvaluation relative to its DCF fair value of $36.57, implying a price discount of over 40% to intrinsic value. Margins are thin (gross margin 6.2%, operating margin 2.9%) and profit margin is only 0.36%, with ROE at 1.3%, underscoring weak earnings generation. The dividend yield of 3.39% looks attractive, but a payout ratio of 359% is clearly unsustainable, raising concerns about future cuts. A recent $500 million senior notes offering adds debt to an already high leverage profile (debt‑to‑equity 46), while the low beta of 0.33 and 30‑day volatility of ~21% suggest limited price swings.
Given the defensive consumer sector backdrop, low liquidity risk, and increasing volume, the stock may hold its current level in the short run, but the combination of overvaluation, fragile profitability, and dividend sustainability issues point to limited upside and potential downside over medium to long horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support at $59.78
  • Oversold RSI indicating possible rebound
  • High dividend payout ratio raising near‑term uncertainty

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Persistent overvaluation relative to DCF
  • Thin operating margins and low ROE
  • Increasing debt load from recent senior notes issuance

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Fundamental overvaluation and unsustainable dividend
  • Weak profitability trends and high leverage
  • Potential for price correction toward intrinsic value

Key Metrics & Analysis

Financial Health

Revenue Growth5.10%
Profit Margin0.36%
P/E Ratio107.6
ROE1.26%
ROA2.17%
Debt/Equity46.04
P/B Ratio1.2
Op. Cash Flow$2.1B
Free Cash Flow$1.2B

Technical Analysis

TrendBullish
RSI36.6
Support$59.78
Resistance$65.95
MA 20$63.23
MA 50$62.05
MA 200$56.77
MACDBearish
VolumeIncreasing
Fear & Greed Index76.91

Valuation

Fair Value$36.57
Target Price$69.08
Upside/Downside14.68%
GradeOvervalued
TypeValue
Dividend Yield3.39%

Risk Assessment

Beta0.33
Volatility20.88%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.